首页> 美国卫生研究院文献>Diagnostics >Urinary Extracellular Vesicles as Biomarkers of Kidney Disease: From Diagnostics to Therapeutics
【2h】

Urinary Extracellular Vesicles as Biomarkers of Kidney Disease: From Diagnostics to Therapeutics

机译:尿液细胞外囊泡作为肾脏疾病的生物标志物:从诊断到治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cell-derived extracellular vesicles (EVs) can be isolated from various body fluids, including urine. Urinary EVs have gained important recognition as potential diagnostic biomarkers in renal disease since their cargo includes nucleic acids, proteins, and other cellular components, which likely mirror the physiological and possibly pathophysiological state of cells along the nephron. Accumulating evidence highlights the feasibility of using EVs as biomarkers for diagnostic, prognostic, and therapeutic purposes in several forms of renal disease, such as acute kidney injury, glomerulonephritis, and renal transplantation. Additionally, exogenous delivery of EVs released in vitro by cells in culture may have salutary benefits for renal diseases. In this review, we introduce recent studies that attempt to identify urinary EVs as candidate biomarkers for human kidney diseases and consider their potential implication as a therapeutic option in key kidney diseases.
机译:可以从包括尿液在内的各种体液中分离出细胞源性细胞外囊泡(EVs)。尿液电动车已包含核酸,蛋白质和其他细胞成分,它们很可能反映了肾单位沿细胞的生理状态和病理生理状态,因此,它们已成为肾脏疾病中潜在的诊断性生物标志物。越来越多的证据表明,在几种形式的肾脏疾病(例如急性肾损伤,肾小球肾炎和肾移植)中,将电动汽车用作生物标记物以进行诊断,预后和治疗目的的可行性。此外,培养细胞在体外释放的EV的外源递送可能对肾脏疾病有益。在这篇综述中,我们介绍了最近的研究,这些研究试图将尿液电动车确定为人类肾脏疾病的候选生物标志物,并将其潜在的影响作为关键性肾脏疾病的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号